{
    "title": "Roche sees slower 2022 sales growth as COVID tests demand eases",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10471429/Roche-sees-slower-2022-sales-growth-COVID-19-test-demand-eases.html",
    "date": "2022-02-03",
    "keywords": [
        "covid19",
        "cancer",
        "roche",
        "demand",
        "immunity",
        "burger",
        "year",
        "coronavirus",
        "company",
        "share",
        "quarter",
        "advantage",
        "drugmaker",
        "growth",
        "population",
        "april",
        "statement",
        "lowsingle",
        "gain",
        "dividend",
        "stock",
        "outlook",
        "group",
        "hemlibra",
        "haemophilia",
        "immunotherapy",
        "tecentriq",
        "decline",
        "antigen",
        "pcr",
        "executive",
        "severin",
        "schwan",
        "call",
        "lab",
        "relief",
        "assumption",
        "duration",
        "vaccination",
        "uncertainty",
        "disease",
        "midyear",
        "maker",
        "supplier",
        "unit",
        "therapy",
        "core",
        "operating",
        "profit",
        "interest",
        "tax",
        "oneoff",
        "line",
        "estimate",
        "analyst",
        "poll",
        "percentage",
        "range",
        "exchange",
        "effect",
        "repurchase",
        "novartis",
        "ronapreve",
        "antibody",
        "treatment",
        "partnership",
        "regeneron",
        "activity",
        "omicron",
        "variant",
        "michael",
        "sitholematarise"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}